App Intel

Cancer Risk Calculator

LiveWestFour1 app · 31.5K installsMedicalFree · contains adsbe.tdf_it.cancerrisk

Calculates your personal risk for a set of cancers based on scientific studies.

Alert me★ WatchOpen in Play ↗
Total installs
31,518
exact · Play shows 10,000+
Installs / day
0
since last crawl
Rating
4.7★
1.2K ratings · 36 reviews
Released
27 Feb 2019
7.6y ago
Last update
3 Sept 2026
v1.4.1 · 1mo ago
Countries
—
not checked yet

Install history

exact counter from Google Play
30.8K35.6K40.4K45.2K50K10 Oct12 Oct13 Oct
30.8K35.6K40.4K45.2K50K10 Oct12 Oct13 Oct

Installs per day · last 90 days

00.30.50.8111 Oct12 Oct13 Oct11 Oct: 012 Oct: 013 Oct: 0

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

estimate · charts of 12 Oct

Most downloads likely come from 🇧🇪 Belgium (~100%).

  1. Belgium100%#45 Top free · Medical

Estimated from top-chart positions weighted by each country’s Google Play market size. Countries where the app is not in a chart are not shown, so small markets may be missing.

Top chart positions

as of 12 Oct
ChartCountryRankChange
Top free · Medical BE#45▲ 2

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Manifest analysis reads only the required APK ranges. Base APK downloads may need separate device splits to install.

Data safety

declared by the developer on Google Play
  • Shares data with third parties Location and Device or other IDs
  • No data collected
  • Data is encrypted in transit
  • No way to ask for data deletion

This is the developer's own declaration, summarised from the Play listing. The permissions below show what the app is technically able to access.

Permissions

3 in 1 group
0 Sensitive1 Notable2 Routine
OtherNotable3

Access to miscellaneous device features that don't fit other categories

  • Keep your phone's processor or screen from going to sleep, which can use more batteryprevent device from sleeping · WAKE_LOCK
  • Check whether you are online and whether you use Wi-Fi or mobile dataview network connections · ACCESS_NETWORK_STATE
  • Connect to the internet to load content and send datafull network access · INTERNET

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description
This application estimates your general risk of cancer, as well as the risk of 38 types of different cancers, based on roughly 650 different risk factors described in the scientific literature. Results are displayed for lifetime risk as well as for 10-, 20- and 30-year timeframes, as well as the risk of death from the cancer in question. A subdivision in anatomical or pathological subtypes is provided if possible. Detailed references are provided for the impact of each risk factor. Additionally, over 90 published & validated cancer models have been included in the application, providing more detail for interested users. This application has the CE conformity mark as a medical device with a low risk. As such, we have followed the Class I conformity assessment procedures as described in Annex VII Module A, EC Declaration of Conformity. As it it is considered a medical device that poses minimal risk to patients and consumers, it falls under the FDA exercise enforcement discretions. For more information, please visit the relevant section the official FDA website: https://www.fda.gov/medical-devices/mobile-medical-applications/examples-mobile-apps-which-fda-will-exercise-enforcement-discretion To use this application, create an account and enter the requested information in the different tabs as accurately and completely as you can. All information that is requested will influence your risk for at least one type of cancer, so the more complete and accurate the information you enter, the more dependable the results. Age, gender and racial background are critical, all other information is optional. The results will appear after you have completed the last tab and can always be revisited by tapping your name. You can also edit the information you submitted to see how this influences your results. The lifetime probabilities of developing cancers were based on USA data from the National Cancer Institute's (NCI's) Surveillance, Epidemiology, and End Results (SEER) Program, collected since 1973 and by the Centers for Disease Control and Prevention's (CDC's) National Program of Cancer Registries (NPCR), collected since 1995. These figures were adapted by the hazard ratios available in the published peer-reviewed literature. Only risk factors with a quantifiable risk were included. Risk factors requiring complex tests not available to the average clinician were excluded. Meta-analyses were given preference when available. DISCLAIMER: This application is strictly educational and all information contained herein cannot and should not replace assessment by a physician. The evaluations presented represent our best efforts to conveniently assess cancer risk. However, as significant controversy and widely different study results can persist around the impact of even a single variable in a strictly selected population, this is based on a large number of assumptions, extrapolations and estimates. As not every study includes a multivariate analysis and the effect of some risk factors on certain cancers is so large their effect cannot be eliminated from basic probability, a bias toward overestimation of risk is possible. Furthermore, there is continuous progress in the scientific literature. Any figures should therefore be regarded as indicative, but not precise. Any information you enter into this application will only be stored on your device and will never be sent to us or to any other party, for any reason. All research and medical support for this application was done by Dr. Philippe Westerlinck, radiation oncologist and clinical chair at the University Hospital of Liège, superspecialising in gastro-intestinal, lung and breast cancers.

What's new

Added more cancer types

Growing in Medical

Category →